Compound 795
Identifiers
- Canonical SMILES:
CCC\C(c1ccccc1)=C1\SC(=S)N(C1=O)[C@H](C(O)=O)CC(C)C
- IUPAC name:
(2S)-4-methyl-2-[(5Z)-4-oxo-5-(1-phenylbutylidene)-2-sulfanylidene-1,3-thiazolidin-3-yl]pentanoic acid
- InChi:
InChI=1S/C19H23NO3S2/c1-4-8-14(13-9-6-5-7-10-13)16-17(21)20(19(24)25-16)15(18(22)23)11-12(2)3/h5-7,9-10,12,15H,4,8,11H2,1-3H3,(H,22,23)/b16-14-/t15-/m0/s1
- InChiKey:
LTESOAGUHITHPM-RIBQPWQFSA-N
External links
44429173 |
CHEMBL242126 |
23291042 |
External search
Bibliography (1)
Publication | Name |
---|---|
Xing C, Wang L, Tang X, Sham YY. . Development of selective inhibitors for anti-apoptotic Bcl-2 proteins from BHI-1. Bioorganic & medicinal chemistry. | 3h |
Pharmacological data
Biochemical tests | Cellular tests | PK tests | Cytotoxicity tests |
---|---|---|---|
2 | 0 | 0 | 0 |
Targets
PPI family | Best activity | Diseases | MMoA |
---|---|---|---|
BCL2-Like / BAX | 4.87 | cancer | Inhibition |
Physicochemical filters
Descriptor | Lipinski's RO5 | Veber | Pfizer's 3/75 | |
---|---|---|---|---|
Compliance | ||||
MW | 377.11 g/mol | |||
HBA | 4 | |||
HBD | 1 | |||
HBA + HBD | 5 | |||
AlogP | 5.45 | |||
TPSA | 57.61 | |||
RB | 7 |
Radar chart
PCA : iPPI-DB chemical space
PCA : Correlation circle
Efficiencies: iPPI-DB biplot LE versus LLE
Summary
Bibliographic ressources | Biochemical tests | Cellular tests | PK tests | Cytotoxicity tests |
---|---|---|---|---|
1 | 2 | 0 | 0 | 0 |
Pharmacological data
Bibliography | Name | Target | Competition | Assay type | Assay name | Cell line | Activity type | Activity |
---|---|---|---|---|---|---|---|---|
17227711 | 3h | BCL2 P10415 |
|
Biochemical assay | Fluorescence Polarization | pKi (inhibition constant, -log10) | 4.87 | |
17227711 | 3h | B2CL2 Q92843 |
|
Biochemical assay | Fluorescence Polarization | pKi (inhibition constant, -log10) | 4.62 |
Ta | Structure | Name | Drugbank ID |
---|---|---|---|
0.6704 | Epalrestat | DB15293 | |
0.5175 | (E)-3-(5((5-(4-CHLOROPHENYL)FURAN-2-YL)METHYLENE)-4-OXO-2-THIOXOTHIAZOLIDIN-3-YL)PROPANOIC ACID | DB08177 | |
0.4930 | (Z)-3-BENZYL-5-(2-HYDROXY-3-NITROBENZYLIDENE)-2-THIOXOTHIAZOLIDIN-4-ONE | DB07838 | |
0.4570 | [(5R)-5-(2,3-dibromo-5-ethoxy-4-hydroxybenzyl)-4-oxo-2-thioxo-1,3-thiazolidin-3-yl]acetic acid | DB06998 | |
0.4000 | (5E)-5-[(2,2-DIFLUORO-1,3-BENZODIOXOL-5-YL)METHYLENE]-1,3-THIAZOLIDINE-2,4-DIONE | DB07503 | |
0.3989 | (5R)-2-sulfanyl-5-[4-(trifluoromethyl)benzyl]-1,3-thiazol-4(5H)-one | DB08574 | |
0.3981 | Omapatrilat | DB00886 | |
0.3980 | 5-QUINOXALIN-6-YLMETHYLENE-THIAZOLIDINE-2,4-DIONE | DB04769 | |
0.3911 | (5E)-2-Amino-5-(2-pyridinylmethylene)-1,3-thiazol-4(5H)-one | DB07529 | |
0.3911 | GSK-1059615 | DB11962 | |
0.3833 | 4-{5-[(Z)-(2-IMINO-4-OXO-1,3-THIAZOLIDIN-5-YLIDENE)METHYL]FURAN-2-YL}BENZOIC ACID | DB07539 | |
0.3824 | CHROMOPHORE (GLU-TYR-GLY) | DB04668 | |
0.3755 | JE-2147 | DB02668 | |
0.3750 | Motuporin | DB04738 | |
0.3750 | (2S)-({(5Z)-5-[(5-Ethyl-2-furyl)methylene]-4-oxo-4,5-dihydro-1,3-thiazol-2-yl}amino)(4-fluorophenyl)acetic acid | DB08706 |